POM · NASDAQ
POMDOCTOR (POM) Stock Price & Fundamentals
POMDOCTOR (POM) closed at $818.51 on Oct 9, 2026, up 0.87% from the previous close of $811.44.
Share price, past year
1Y +16.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $818.51 |
| Sep 30, 2026 | $814.39 |
| Aug 31, 2026 | $832.19 |
| Jul 31, 2026 | $811.84 |
| Jun 30, 2026 | $788.30 |
| May 29, 2026 | $740.17 |
| Apr 30, 2026 | $723.76 |
| Mar 31, 2026 | $794.09 |
| Feb 27, 2026 | $811.30 |
| Jan 30, 2026 | $736.85 |
| Dec 31, 2025 | $743.25 |
| Nov 28, 2025 | $715.82 |
| Oct 31, 2025 | $680.27 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $678.94 – $870.24
Market cap, P/E and dividend yield aren't shown for POMDOCTOR yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Chinese yuan.
Financials
POMDOCTOR reported revenue of CN¥399.91M for fiscal 2025, up 16.74% from fiscal 2024.
Figures are in Chinese yuan (CNY), as POMDOCTOR reports them to the SEC.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | CN¥399.91M | +16.7% | — | — | −CN¥21.96 | −CN¥149.49M |
| FY2024ended Dec 31, 2024 | CN¥342.56M | +12.4% | — | — | −CN¥22.72 | −CN¥16.17M |
| FY2023ended Dec 31, 2023 | CN¥304.85M | — | — | — | −CN¥23.04 | −CN¥45.91M |
Company profile
- Name
- POMDOCTOR Ltd
- Ticker
- POM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Retail-Miscellaneous Retail
- Headquarters
- Yongxu Industrial Park, No.19-23, Hejing Rd, Liwan District, Guangzhou
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001877971
Recent SEC filings
- May 14, 2026
Frequently asked questions
What is POMDOCTOR's stock price?
POMDOCTOR (POM) closed at $818.51 on Oct 9, 2026, up 0.87% from the previous close of $811.44.
How much revenue does POMDOCTOR make?
POMDOCTOR reported revenue of CN¥399.91M for fiscal 2025, up 16.74% from fiscal 2024.
Sources and methodology
Fundamentals come from POMDOCTOR Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures